Article info
Review
Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
- Correspondence to Gabor Valcz, 2nd Department of Internal Medicine, Szentkirályi u. 46, Budapest H-1088, Hungary; valczg{at}yahoo.com
Citation
Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
Publication history
- Received July 14, 2014
- Accepted July 28, 2014
- First published August 18, 2014.
Online issue publication
November 14, 2014
Article Versions
- Previous version (18 August 2014).
- Previous version (21 August 2014).
- You are viewing the most recent version of this article.
Abstract in Hungarian
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Abstract in Hungarian - Online abstract
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions